What is Tazverik (tazemetostat) and How Does It Work?
•
4 min read
Over 90% of epithelioid sarcomas feature a loss of the INI1 protein, a key trigger for the cancerous activity that Tazverik is designed to inhibit. So, **what is Tazverik?** It's a targeted oral cancer medication, not a traditional chemotherapy.
